LifeWatch AG

EQS-Adhoc: LifeWatch AG: LifeWatch turns the page on key legal matters


EQS Group-Ad-hoc: LifeWatch AG / Key word(s): Letter of Intent
LifeWatch AG: LifeWatch turns the page on key legal matters

01.06.2016 / 18:00
Release of an ad hoc announcement pursuant to Art. 53 KR.
The issuer is solely responsible for the content of this announcement.

--------------------------------------------------------------------------------
LifeWatch turns the page on key legal matters

Zug/Switzerland, June 1, 2016 - LifeWatch AG (SIX Swiss Exchange: LIFE), a
leading developer and provider of medical solutions and remote diagnostic
monitoring services in the digital health market, reports that its subsidiary,
LifeWatch Services, Inc. and Highmark Blue Cross Blue Shield, a private health
insurer, agreed to a compromise on the previously announced, International
Arbitration award related to LifeWatch's practices billing in the years
2009-2010. Highmark agreed to reduce its entitlement from approximately
$22,000,000 ($18,700,000 plus interest) to $13,000,000. In return, LifeWatch
agreed to release Highmark Inc. and its affiliates from the antitrust case
LifeWatch has pending against Highmark and the Blue Cross Blue Shield
Association and other Blue Cross Blue Shield affiliates. The settlement
agreement is conditional upon payment being made by August 15, 2016 at the
latest, which is following LifeWatch AG's capital increase.

Today LifeWatch also announces a preliminary settlement in the case of United
States, et. al., ex. rel. Cieszynski v. LifeWatch Services, Inc. (qui
tamaction). This case contained allegations related to billing processes for
clinical services provided off shore and was filed against LifeWatch in May of
2013. The parties recently signed a Memorandum of Understanding agreeing to pay
a total of $12,750.000 to the United States Government and the Relator and are
awaiting approval from the Department of Justice. While LifeWatch vehemently
denies any wrongdoing, the company nonetheless agreed to a settlement to
eliminate any possible unknown exposure and to allow LifeWatch to focus on the
future rather than the past. This payment will also be made after the capital
increase is completed.

Dr. Stephan Rietiker, CEO of LifeWatch, stated: "The settlements announced
today, while painful for the company, will allow LifeWatch to put the past
behind and focus on growing the business and providing world-class diagnostic
services for our patients. Collectively, these settlements amount to only
slightly more than the reserves set forth in the 2015 Annual Report.


For further questions:
Andrew Moore, CFO LifeWatch AG
c/o Dynamics Group, Doris Rudischhauser
Phone +41 43 268 32 32 / +41 79 410 81 88
investor-relations@lifewatch.com


About LifeWatch AG

LifeWatch AG, headquartered in Zug and listed on SIX Swiss Exchange (LIFE),
Switzerland, is a leading healthcare technology and solution company,
specializing in advanced digital health systems and wireless remote diagnostic
patient monitoring services. LifeWatch's services provide physicians with
critical information to determine appropriate treatment and thereby improve
patient outcomes. LifeWatch AG has operative subsidiaries in the United States,
in Switzerland and in Israel, and is the parent company of LifeWatch Services
Inc., and LifeWatch Technologies, Ltd. LifeWatch Services, Inc. is a leading
U.S.-based provider of cardiac monitoring services and home sleep testing of
Obstructive Sleep Apnea (OSA). LifeWatch Technologies Ltd., based in Israel, is
a leading developer and manufacturer of telemedicine products. For additional
information, please visitwww.lifewatch.com.

Sign up for customized e-mail alerts and documentation requests at
http://www.irlifewatch.com/websites/lifewatch_ir/English/9510/alert-service.html

This press release includes forward-looking statements. All statements other
than statements of historical facts contained in this press release, including
statements regarding future results of operations and financial position, the
business strategy, and plans and objectives for future operations, are
forward-looking statements. The words "believe," "may," "will," "estimate,"
"continue," "anticipate," "intend," "expect" and similar expressions are
intended to identify forward-looking statements. LifeWatch AG has based these
forwardlooking statements largely on current expectations and projections about
future events and financial trends that it believes may affect the financial
condition, results of operations, business strategy, short-term and long-term
business operations and objectives, and financial needs. These forward-looking
statements are subject to a number of risks, uncertainties and assumptions. In
light of these risks, uncertainties and assumptions, the forward-looking events
and circumstances described may not occur and actual results could differ
materially and adversely from those anticipated or implied in the
forward-looking statements. All forward-looking statements are based only on
data available to LifeWatch AG at the time of the issue of this press release.
LifeWatch AG does not undertake any obligation to update any forward-looking
statements contained in this press release as a result of new information,
future events or otherwise.

THIS PRESS RELEASE IS NOT BEING ISSUED IN THE UNITED STATES OF AMERICA AND
SHOULD NOT BE DISTRIBUTED TO UNITED STATES PERSONS OR PUBLICATIONS WITH A
GENERAL CIRCULATION IN THE UNITED STATES. THIS PRESS RELEASE DOES NOT CONSTITUTE
AN OFFER OF SECURITIES OF LIFEWATCH AG OR ANY OF ITS SUBSIDIARIES FOR SALE IN
THE UNITED STATES, OR AN INVITATION TO SUBSCRIBE FOR OR PURCHASE ANY SECURITIES
OF LIFEWATCH AG OR ITS SUBSIDIARIES IN THE UNITED STATES. IN ADDITION, THE
SECURITIES OF LIFEWATCH AG AND ITS SUBSIDIARIES HAVE NOT BEEN REGISTERED UNDER
THE UNITED STATES SECURITIES LAWS AND MAY NOT BE OFFERED, SOLD OR DELIVERED
WITHIN THE UNITED STATES OR TO U.S. PERSONS ABSENT FROM REGISTRATION UNDER OR AN
APPLICABLE EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE UNITED STATES
SECURITIES LAWS. ANY PUBLIC OFFERING OF SECURITIES TO BE MADE IN THE UNITED
STATES WILL BE MADE BY MEANS OF A PROSPECTUS THAT MAY BE OBTAINED FROM LIFEWATCH
AG OR ITS SUBSIDIARIES, AS APPLICABLE, AND WILL CONTAIN DETAILED INFORMATION
ABOUT THE ISSUER AND ITS MANAGEMENT AS WELL AS FINANCIAL STATEMENTS OF THE
ISSUER.

End of ad hoc announcement
Additional features:


Document:http://n.eqs.com/c/fncls.ssp?u=LIXQWJOPJV
Document title: LifeWatch turns the page on key legal matters

--------------------------------------------------------------------------------
01.06.2016 News transmitted by Tensid EQS AG. www.eqs.com

The issuer is responsible for the contents of the release.
--------------------------------------------------------------------------------

Language: English

Company:  LifeWatch AG

          Baarerstrasse 139

          6300  Zug

          Switzerland

Phone:    +41 41 728 67 78

Internet: www.lifewatch.com

ISIN:     CH0012815459

Valor:    811189

Listed:   Regulated Unofficial Market in Berlin, Stuttgart; Open Market in
Frankfurt ; SIX


End of News EQS Group News Service
--------------------------------------------------------------------------------
468329  01.06.2016 
 



Weitere Meldungen: LifeWatch AG

Das könnte Sie auch interessieren: